TABLE 2.
Temporizing management | Immediate delivery | |
---|---|---|
(n = 30) | (n = 26) | |
At start of pregnancy | ||
Maternal age, yr (mean, SD) | 29.2 (4.6) | 28.7 (5.4) |
Ethnicity | ||
Caucasian | 21 (70%) | 15 (58%) |
Other | 9 (30%) | 11 (42%) |
Highest level of education | ||
Primary or secondary school | 0 (0%) | 0 (0%) |
Lower/medium professional education | 6 (20%) | 6 (21%) |
Higher professional education/ university | 2 (7%) | 2 (8%) |
Other/unknown | 22 (73%) | 16 (61%) |
Current pregnancy: | ||
Singleton | 29 (97%) | 22 (85%) |
Twin | 1 (3%) | 3 (12%) |
Triplet | 0 (0%) | 1 (4%) |
Parity | ||
Nulliparous | 22 (73%) | 12 (46%) |
Primi‐ and multiparous | 8 (27%) | 14 (54%) |
Preeclampsia in previous pregnancy a | 5/8 (63%) | 9/14 (64%) |
Blood pressure, at booking (mm Hg) | ||
Systolic | 118 (9.6) | 135 (22.9) |
Diastolic | 74 (8.1) | 80 (16.4) |
BMI at booking >35 | 1 (3%) | 4 (15%) |
At start study | ||
Gestational age (days) | 214 (12.6) | 216 (10.7) |
Inclusion for: b | ||
Clinical symptoms | 23 (77%) | 17 (68%) |
Laboratory abnormalities | 10 (33%) | 11 (42%) |
Severe hypertension | 20 (67%) | 12 (46%) |
Proteinuria (>300 mg/day) | 28 (100%) | 25 (100%) |
Protein‐to‐creatinine ratio (mg/mmol) | 184 (93‐460) | 73.5 (28‐174) |
Blood pressure, at inclusion (mm Hg) | ||
Systolic | 154 (30.1) | 153 (17.0) |
Diastolic | 99 (10.8) | 93 (10.6) |
Smoking | ||
No | 24 (80%) | 18 (69%) |
Stopped in 1st or 2nd trimester | 4/29 (14%) | 4/25 (16%) |
Unknown | 2 (7%) | 4 (15%) |
Antihypertensive medication at study entry | ||
Oral | 27/29 (93%) | 22 (85%) |
Intravenous | 15/29 (52%) | 13/24 (54%) |
Anticonvulsive medication (including magnesium sulfate) | 25/26 (96%) |
20 (77%) |
BMI, body mass index.
Numerator: primi‐ and multiparous women.
Multiple inclusion criteria possible.